Login to Your Account



Other News To Note


Friday, August 12, 2011
• Neoprobe Corp., of Dublin, Ohio, submitted a new drug application to the FDA for Lymphoseek (tilmanocept) for use in intraoperative lymphatic mapping. The procedure, which identifies and biopsies lymph nodes draining the area around a tumor, is used primarily in melanoma and breast cancer.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription